Johnson & Johnson (JNJ)
156.97
+2.43
(+1.57%)
USD |
NYSE |
Jun 02, 16:00
156.80
-0.17
(-0.11%)
Pre-Market: 20:00
Johnson & Johnson Profit Margin (Quarterly): -0.27% for March 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2023 | -0.27% |
| December 31, 2022 | 14.85% |
| September 30, 2022 | 18.74% |
| June 30, 2022 | 20.04% |
| March 31, 2022 | 21.98% |
| December 31, 2021 | 19.09% |
| September 30, 2021 | 15.71% |
| June 30, 2021 | 26.93% |
| March 31, 2021 | 27.76% |
| December 31, 2020 | 7.73% |
| September 30, 2020 | 16.86% |
| June 30, 2020 | 19.78% |
| March 31, 2020 | 28.01% |
| December 31, 2019 | 19.33% |
| September 30, 2019 | 8.46% |
| June 30, 2019 | 27.27% |
| March 31, 2019 | 18.73% |
| December 31, 2018 | 14.92% |
| September 30, 2018 | 19.33% |
| June 30, 2018 | 18.98% |
| March 31, 2018 | 21.83% |
| December 31, 2017 | -53.05% |
| September 30, 2017 | 19.16% |
| June 30, 2017 | 20.31% |
| March 31, 2017 | 24.89% |
| Date | Value |
|---|---|
| December 31, 2016 | 21.06% |
| September 30, 2016 | 23.97% |
| June 30, 2016 | 21.63% |
| March 31, 2016 | 25.49% |
| December 31, 2015 | 18.05% |
| September 30, 2015 | 19.64% |
| June 30, 2015 | 25.39% |
| March 31, 2015 | 24.86% |
| December 31, 2014 | 13.81% |
| September 30, 2014 | 25.72% |
| June 30, 2014 | 22.19% |
| March 31, 2014 | 26.09% |
| December 31, 2013 | 19.17% |
| September 30, 2013 | 16.97% |
| June 30, 2013 | 21.44% |
| March 31, 2013 | 19.98% |
| December 31, 2012 | 14.62% |
| September 30, 2012 | 17.41% |
| June 30, 2012 | 8.55% |
| March 31, 2012 | 24.23% |
| December 31, 2011 | 1.34% |
| September 30, 2011 | 20.01% |
| June 30, 2011 | 16.73% |
| March 31, 2011 | 21.49% |
| December 31, 2010 | 12.41% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-0.27%
Minimum
Mar 2023
28.01%
Maximum
Mar 2020
18.21%
Average
19.04%
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 46.54% |
| Gilead Sciences Inc | 15.90% |
| Eli Lilly and Co | 19.32% |
| Merck & Co Inc | 19.47% |
| Moderna Inc | 4.30% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.04% |
| Return on Assets | 6.96% |
| Return on Invested Capital | 11.29% |
| Gross Profit Margin (Quarterly) | 66.08% |
| Operating Margin (Quarterly) | 28.29% |
| Return on Net Operating Assets | 9.53% |